http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112830969-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate | 2021-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112830969-B |
titleOfInvention | A monoclonal antibody that specifically binds to human Claudin18.2 and medicine and kit comprising the same |
abstract | The present invention discloses a monoclonal antibody that specifically binds to human Claudin18.2, comprising a heavy chain variable region and a light chain variable region; the heavy chain variable region includes: as shown in SEQ ID NO: 1 The heavy chain variable region CDR1, the heavy chain variable region CDR2 shown in SEQ ID NO:2, and the heavy chain variable region CDR3 shown in SEQ ID NO:3; the light chain variable region includes : light chain variable region CDR1 shown in SEQ ID NO:4, light chain variable region CDR2 shown in SEQ ID NO:5, and light chain variable region CDR3 shown in SEQ ID NO:6. The present invention also discloses a bispecific antibody based on the above-mentioned monoclonal antibody, and a medicament or kit for treating or alleviating cancer based on the above-mentioned monoclonal antibody or specific antibody. |
priorityDate | 2021-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 522.